tradingkey.logo

Embecta Corp

EMBC
12.080USD
+0.160+1.34%
Cierre 12/24, 13:00ETCotizaciones retrasadas 15 min
706.63MCap. mercado
7.38P/E TTM

Más Datos de Embecta Corp Compañía

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Información de Embecta Corp

Símbolo de cotizaciónEMBC
Nombre de la empresaEmbecta Corp
Fecha de salida a bolsaMar 21, 2022
Director ejecutivoKurdikar (Devdatt)
Número de empleados1850
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección300 Kimball Drive
CiudadPARSIPPANY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07054
Teléfono18624010000
Sitio Webhttps://www.embecta.com/
Símbolo de cotizaciónEMBC
Fecha de salida a bolsaMar 21, 2022
Director ejecutivoKurdikar (Devdatt)

Ejecutivos de Embecta Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Pravesh Khandelwal
Mr. Pravesh Khandelwal
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
160.20M
54.21%
International
135.30M
45.79%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
Otro
58.93%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
Otro
58.93%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.94%
Investment Advisor/Hedge Fund
31.49%
Hedge Fund
10.58%
Research Firm
5.48%
Pension Fund
2.25%
Individual Investor
1.46%
Bank and Trust
0.54%
Family Office
0.40%
Sovereign Wealth Fund
0.19%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
771
58.75M
107.09%
-8.51K
2025Q3
810
58.76M
110.40%
-1.03M
2025Q2
820
59.48M
109.25%
+307.16K
2025Q1
855
59.15M
106.14%
-2.75M
2024Q4
884
57.08M
105.66%
+385.73K
2024Q3
903
56.12M
114.14%
-1.32M
2024Q2
966
57.37M
112.89%
+262.03K
2024Q1
996
57.10M
113.18%
-8.07M
2023Q4
1007
56.71M
107.91%
+769.57K
2023Q3
972
57.63M
107.02%
+1.71M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
8.03M
13.73%
-278.98K
-3.36%
Jun 30, 2025
The Vanguard Group, Inc.
5.40M
9.24%
-1.27M
-19.01%
Jun 30, 2025
American Century Investment Management, Inc.
5.20M
8.88%
+1.38M
+36.25%
Jun 30, 2025
River Road Asset Management, LLC
3.24M
5.54%
+12.35K
+0.38%
Jun 30, 2025
Deerfield Management Company, L.P.
2.75M
4.7%
+29.18K
+1.07%
Jun 30, 2025
State Street Investment Management (US)
2.40M
4.1%
+15.14K
+0.64%
Jun 30, 2025
Yacktman Asset Management LP
2.37M
4.06%
+16.07K
+0.68%
Jun 30, 2025
Jefferies LLC
1.34M
2.3%
+769.71K
+134.33%
Jun 30, 2025
William Blair Investment Management, LLC
1.99M
3.41%
+14.23K
+0.72%
Jun 30, 2025
Millennium Management LLC
1.82M
3.12%
+937.99K
+105.75%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
ETC 6 Meridian Small Cap Equity ETF
1.09%
State Street SPDR S&P Health Care Equipment ETF
0.85%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
Invesco S&P Spin-Off ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.49%
Invesco S&P SmallCap Health Care ETF
0.48%
Global X Aging Population ETF
0.31%
Royce Quant Small-Cap Quality Value ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.19%
Ver más
ETC 6 Meridian Small Cap Equity ETF
Proporción1.09%
State Street SPDR S&P Health Care Equipment ETF
Proporción0.85%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.65%
Invesco S&P Spin-Off ETF
Proporción0.63%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.49%
Invesco S&P SmallCap Health Care ETF
Proporción0.48%
Global X Aging Population ETF
Proporción0.31%
Royce Quant Small-Cap Quality Value ETF
Proporción0.29%
Inspire Small/Mid Cap ESG ETF
Proporción0.19%

Dividendos

Un total de 112.50M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Aug 08, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
May 09, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2025 going ex on May 28, 2025
May 28, 2025
Jun 13, 2025
May 28, 2025
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
Aug 08, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Sep 13, 2023
Aug 24, 2023
May 12, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2023 going ex on May 25, 2023
May 29, 2023
Jun 13, 2023
May 25, 2023
Ver más

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Embecta Corp?

Los cinco principales accionistas de Embecta Corp son:
BlackRock Institutional Trust Company, N.A. posee 8.03M acciones, lo que representa el 13.73% del total de acciones.
The Vanguard Group, Inc. posee 5.40M acciones, lo que representa el 9.24% del total de acciones.
American Century Investment Management, Inc. posee 5.20M acciones, lo que representa el 8.88% del total de acciones.
River Road Asset Management, LLC posee 3.24M acciones, lo que representa el 5.54% del total de acciones.
Deerfield Management Company, L.P. posee 2.75M acciones, lo que representa el 4.70% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Embecta Corp?

Los tres principales tipos de accionista de Embecta Corp son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.

¿Cuántas instituciones poseen acciones de Embecta Corp (EMBC)?

A fecha de 2025Q4, 771 instituciones poseen acciones de Embecta Corp, con un valor de mercado combinado de aproximadamente 58.75M, lo que representa el 107.09% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -3.30%.

¿Cuál es la mayor fuente de ganancias de Embecta Corp?

El FY2025Q3, el segmento empresarial Pen Needles generó la ganancia más alta para Embecta Corp, ascendiendo a 216.90M y representando el 73.40% de la ganancia total.
KeyAI